News
-
-
PRESS RELEASE
EQS-Adhoc: audius SE: audius increases total operating performance in H1 2024 / 2nd quarter with clearly positive momentum / strong order intake / forecast adjustment
audius SE increases total operating performance in H1 2024 & 2nd quarter with positive momentum, strong order intake & forecast adjustment amidst challenging environment -
-
-
-
PRESS RELEASE
Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates research on Valneva SE (ISIN: FR0004056851) with a BUY recommendation and EUR 8.60 price target. H1 product sales slightly below consensus but gross margin improving. Valneva maintains full-year guidance -
PRESS RELEASE
Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award
Jaguar Health announces Eduardo Zimmer as 2024 Blas Frangione Early Career Achievement Award recipient for work with Magdalena Biosciences on plant-based mental health medicines -
-
-